Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/beta-catenin signaling activation (Review).
Katoh M.
Int J Mol Med. 2018 Aug;42(2):713-725. doi: 10.3892/ijmm.2018.3689. Epub 2018 May 17.
Nonalcoholic Fatty Liver Disease and Obesity Treatment.
Brunner KT, Henneberg CJ, Wilechansky RM, Long MT.
Curr Obes Rep. 2019 Sep;8(3):220-228. doi: 10.1007/s13679-019-00345-1.
Azithromycin: mechanisms of action and their relevance for clinical applications.
Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R.
Pharmacol Ther. 2014 Aug;143(2):225-45. doi: 10.1016/j.pharmthera.2014.03.003. Epub 2014 Mar 11.
Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis.
He Y, Zeng HZ, Yu Y, Zhang JS, Duan X, Zeng XN, Gong FT, Liu Q, Yang B.
Environ Toxicol Pharmacol. 2017 Sep;54:120-124. doi: 10.1016/j.etap.2017.06.025. Epub 2017 Jul 1.
Resveratrol reduces inflammation-related Prostate Fibrosis.
Vicari E, Arancio A, Catania VE, Vicari BO, Sidoti G, Castiglione R, Malaguarnera M.
Int J Med Sci. 2020 Jul 19;17(13):1864-1870. doi: 10.7150/ijms.44443. eCollection 2020.
Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review.
Alugoju P, Krishna Swamy VKD, Anthikapalli NVA, Tencomnao T.
Crit Rev Food Sci Nutr. 2023;63(31):10709-10774. doi: 10.1080/10408398.2022.2084600. Epub 2022 Jun 16.
Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis by mast cell suppression.
Zeng H, He Y, Yu Y, Zhang J, Zeng X, Gong F, Liu Q, Yang B.
Mol Med Rep. 2018 Jan;17(1):918-924. doi: 10.3892/mmr.2017.7960. Epub 2017 Nov 3.
Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic Prostatitis.
Lin D, Zhang M, Luo C, Wei P, Cui K, Chen Z.
J Immunol Res. 2022 Jun 17;2022:6833867. doi: 10.1155/2022/6833867. eCollection 2022.
Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, Abrams JM, Adam D, Agostini M, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Aqeilan RI, Arama E, Baehrecke EH, Balachandran S, Bano D, Barlev NA, Bartek J, Bazan NG, Becker C, Bernassola F, Bertrand MJM, Bianchi ME, Blagosklonny MV, Blander JM, Blandino G, Blomgren K, Borner C, Bortner CD, Bove P, Boya P, Brenner C, Broz P, Brunner T, Damgaard RB, Calin GA, Campanella M, Candi E, Carbone M, Carmona-Gutierrez D, Cecconi F, Chan FK, Chen GQ, Chen Q, Chen YH, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Ciliberto G, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Daugaard M, Dawson TM, Dawson VL, De Maria R, De Strooper B, Debatin KM, Deberardinis RJ, Degterev A, Del Sal G, Deshmukh M, Di Virgilio F, Diederich M, Dixon SJ, Dynlacht BD, El-Deiry WS, Elrod JW, Engeland K, Fimia GM, Galassi C, Ganini C, Garcia-Saez AJ, Garg AD, Garrido C, Gavathiotis E, Gerlic M, Ghosh S, Green DR, Greene LA, Gronemeyer H, Häcker G, Hajnóczky G, Hardwick JM, Haupt Y, He S, Heery DM, Hengartner MO, Hetz C, Hildeman DA, Ichijo H, Inoue S, Jäättelä M, Janic A, Joseph B, Jost PJ, Kanneganti TD, Karin M, Kashkar H, Kaufmann T, Kelly …
Cell Death Differ. 2023 May;30(5):1097-1154. doi: 10.1038/s41418-023-01153-w. Epub 2023 Apr 26.
Editorial Comment to Metabolic syndrome correlates with peri-urethral fibrosis secondary to chronic prostate inflammation: evidence of a link in a cohort of patients undergoing radical prostatectomy.
Miyake H, Fujisawa M.
Int J Urol. 2014 Mar;21(3):270. doi: 10.1111/iju.12252. Epub 2013 Aug 15.
